San Diego-based Cytori Therapeutics Inc. announced that Tiago Girão has been appointed vice president and chief financial officer.

Girão previously served as international controller at NuVasive Inc., a San Diego-based medical device company.

“Mr. Girão is an ideal candidate to take over the role,” said Marc Hedrick, president and CEO of Cytori. “He has a particularly strong background in public company finance and accounting practices as well as international operations, all important issues for us today. The added benefit to Cytori is that he has an in-depth, long standing knowledge of Cytori’s technology and history from his previous tenure at KPMG in which he functioned as the senior account manager for Cytori. This will enable him to get up to speed quickly and we are extremely excited to have him on our team.”

Cytori (Nasdaq: CYTX) is developing cell therapies to treat cardiovascular disease and other medical conditions.